Secretome Therapeutics logo
Healthcare & Life Sciences

Secretome Therapeutics

Secretome Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 2 tracked investors.

Activeseries-b
series-b
Stage
2
Investors

About Secretome Therapeutics

Secretome Therapeutics is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

Secretome Therapeutics develops scalable neonatal cell-based therapies derived from neonatal cardiac progenitor cells to treat heart failure and dilated cardiomyopathy, focusing on consistent, potent, and ethical stem cell therapies with ongoing early-stage clinical trials.

Explore Secretome Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States